HRP20080274T3 - 2-(1h-indolilsulfanil)-benzil amin derivati kao ssri - Google Patents
2-(1h-indolilsulfanil)-benzil amin derivati kao ssriInfo
- Publication number
- HRP20080274T3 HRP20080274T3 HR20080274T HRP20080274T HRP20080274T3 HR P20080274 T3 HRP20080274 T3 HR P20080274T3 HR 20080274 T HR20080274 T HR 20080274T HR P20080274 T HRP20080274 T HR P20080274T HR P20080274 T3 HRP20080274 T3 HR P20080274T3
- Authority
- HR
- Croatia
- Prior art keywords
- indolylsulfanyl
- ssri
- amine derivatives
- benzyl amine
- benzyl
- Prior art date
Links
- -1 2-(1h-indolylsulfanyl)-benzyl Chemical group 0.000 title abstract 2
- 208000019022 Mood disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Spoj opće formule 1 : u kojem je atom sumpora pričvršćen na indol preko ugljikovog prstena indola iu kojem- R1-R2 se nezavisno biraju iz vodika, C1-6-alk(en/in)il, C3-8-cikloalk(en)il i C3-8-cikloalk(en), ili R1 i R2 zajedno s dušikom tvore 4-7-člani prsten koji sadrži nula ili jednu dvostruku svezu a, opcionalno, rečeni prsten, uz rečeni dušik, sadrži i još jedan heteroatom izabran iz dušika, kisika i sumpora; - R3-R12 se nezavisno biraju iz vodika, halogena, cijana, nitro, C1-6-alk(en/in)il,C3-8-cikloalk(en)il, C3-8-cikloalk(en)il-C1-6-alk(en/in)il, amino, C1-6-alk(en/in)ilamino, di-(C1-6-alk(en/in)il)amino, C1-6-alk(en/in)ilkarbonil, aminokarbonil, C1-6-alk(en/in)ililaminokarbonil, di-(C1-6-alk(en/in)il)aminokarbonil, hidroksi, C1-6-alk(en/in)iloksi, C1-6-alk(en/in)iltio, halo-C1-6-alk(en/in)il, halo-C1-6-alk(en/in)ilsulfonil, halo-C1-6-alk(en/in)ilsulfanil i C1-6-alk(en/in)ilsulfonil i- R13 se bira iz vodika i C1-6-alkil- pod uvjetom da se R10 bira iz vodika, halogena, cijana, C1-6-alk(en/in)il, hidroksil, i halo-C1-6-alk(en/in)il kao slobodna baza ili njezina sol, pod uvjetomda- ako je atom sumpora pričvršćen preko atoma br. 2 indola, tada R7 ne postoji; - ako je atom sumpora pričvršćen preko atoma br. 3 indola, tada R12 ne postoji; - ako je atom sumpora pričvršćen prekoatoma br. 4 indola, tada R8 ne postoji; - ako je atom sumpora pričvršćen preko atoma br. 5 indola, tada R9 ne postojiako je atom sumpora pričvršćen preko atoma br. 7 indola, tada R11 ne postoji. Patent sadrži još 16 patentnih zahtjeva.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53259303P | 2003-12-23 | 2003-12-23 | |
DKPA200301923 | 2003-12-23 | ||
PCT/DK2004/000894 WO2005061455A1 (en) | 2003-12-23 | 2004-12-21 | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20080274T3 true HRP20080274T3 (hr) | 2008-12-31 |
Family
ID=34712442
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20080274T HRP20080274T3 (hr) | 2003-12-23 | 2008-06-19 | 2-(1h-indolilsulfanil)-benzil amin derivati kao ssri |
HR20110400T HRP20110400T1 (hr) | 2003-12-23 | 2011-05-27 | Derivati 2-(1h-indolilsulfanil)-benzil amina kao ssri |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20110400T HRP20110400T1 (hr) | 2003-12-23 | 2011-05-27 | Derivati 2-(1h-indolilsulfanil)-benzil amina kao ssri |
Country Status (18)
Country | Link |
---|---|
US (4) | US7563908B2 (hr) |
EP (1) | EP1701940B1 (hr) |
JP (3) | JP4090491B2 (hr) |
AT (1) | ATE396970T1 (hr) |
AU (1) | AU2004303461B2 (hr) |
BR (1) | BRPI0417858B1 (hr) |
CY (2) | CY1108230T1 (hr) |
DE (1) | DE602004014190D1 (hr) |
DK (1) | DK1701940T3 (hr) |
ES (1) | ES2303960T3 (hr) |
HR (2) | HRP20080274T3 (hr) |
IL (1) | IL176111A (hr) |
MX (1) | MXPA06007172A (hr) |
PL (1) | PL1701940T3 (hr) |
PT (1) | PT1701940E (hr) |
RS (1) | RS50589B (hr) |
SI (1) | SI1701940T1 (hr) |
WO (1) | WO2005061455A1 (hr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1701940T3 (pl) * | 2003-12-23 | 2008-11-28 | H Lundbeck As | Pochodne 2-(1H-indolilosulfanylo)benzyloaminy jako SSRI |
AR052308A1 (es) | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
AR054394A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de 2- (1h-indolilsulfanil)-aril amina |
AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
EP1996948A1 (en) * | 2006-03-22 | 2008-12-03 | H.Lundbeck A/S | Method for identifying compounds for the treatment of depression |
TW200819426A (en) | 2006-08-31 | 2008-05-01 | Lundbeck & Co As H | Novel indane compounds |
MX2009003299A (es) * | 2006-09-28 | 2009-04-09 | Lundbeck & Co As H | [2-(6-fluor-1h-indol-3-ilsulfanil)bencil]metilamina para el tratamiento de trastornos afectivos. |
ZA200901739B (en) * | 2006-09-28 | 2010-06-30 | Lundbeck & Co As H | [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
CN101868233A (zh) * | 2007-09-24 | 2010-10-20 | H.隆德贝克有限公司 | 与血清素双重作用化合物有关的组合疗法 |
TW200938189A (en) * | 2008-03-13 | 2009-09-16 | Lundbeck & Co As H | [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
WO2010006945A1 (en) | 2008-07-15 | 2010-01-21 | F. Hoffmann-La Roche Ag | Substituted indolyl and indazolyl derivatives and uses thereof |
US9000025B2 (en) | 2010-08-20 | 2015-04-07 | Amira Pharmaceuticals, Inc. | Autotaxin inhibitors and uses thereof |
EP2714680B1 (en) | 2011-05-27 | 2015-11-25 | Amira Pharmaceuticals, Inc. | Heterocyclic autotaxin inhibitors and uses thereof |
JP2016530210A (ja) | 2013-09-17 | 2016-09-29 | ファーマケア,インク. | ヘテロ環式ビニルオートタキシン阻害剤化合物 |
EP3046905A4 (en) | 2013-09-17 | 2017-03-22 | Pharmakea Inc. | Vinyl autotaxin inhibitor compounds |
US9850203B2 (en) | 2013-09-26 | 2017-12-26 | Pharmakea, Inc. | Autotaxin inhibitor compounds |
MY182095A (en) | 2013-11-22 | 2021-01-18 | Sabre Therapeutics Llc | Autotaxin inhibitor compounds |
MX2017015225A (es) | 2015-05-27 | 2018-02-19 | Pharmakea Inc | Inhibidores de la autotaxina y sus usos. |
US11339144B2 (en) | 2017-04-10 | 2022-05-24 | Navitor Pharmaceuticals, Inc. | Heteroaryl Rheb inhibitors and uses thereof |
Family Cites Families (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2003023A (en) * | 1930-10-16 | 1935-05-28 | Westinghouse Electric & Mfg Co | Mercury vapor or noble gas rectifier with arc control |
US3803143A (en) | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
US4018830A (en) | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
US4055665A (en) | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
US4056632A (en) | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
US4241071A (en) | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
US4198417A (en) | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
DE3640475A1 (de) | 1986-11-27 | 1988-06-09 | Hoechst Sa Lab | Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung |
EP0396827A1 (en) | 1989-05-09 | 1990-11-14 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof |
GB8912971D0 (en) | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
US6645969B1 (en) | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
WO1993011106A1 (en) * | 1991-11-25 | 1993-06-10 | Pfizer, Inc. | Indole derivatives |
GB9126311D0 (en) | 1991-12-11 | 1992-02-12 | Wellcome Found | Substituted diphenylsulfides |
GB9226532D0 (en) | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
AU2395095A (en) | 1994-04-29 | 1995-11-29 | G.D. Searle & Co. | Method of using (h+/k+) atpase inhibitors as antiviral agents |
CA2185984C (en) | 1995-01-23 | 2007-12-04 | Hirokazu Annoura | Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor |
DE907654T1 (de) | 1995-11-06 | 1999-09-16 | Gist Brocades Bv | Verfahren zur de-esterifikation |
CZ293595A3 (cs) | 1995-11-09 | 1999-12-15 | Farmak A. S. | Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích |
US5912256A (en) | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
EP0923548B1 (en) * | 1996-08-27 | 2003-03-12 | Wyeth | 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht 1a ligands |
US5906078A (en) * | 1996-10-09 | 1999-05-25 | Gallagher-Kaiser Corporation | Retaining strip for sheet covered enclosures |
GB9725953D0 (en) | 1997-12-08 | 1998-02-04 | Pfizer Ltd | Compounds useful in therapy |
DE19756036A1 (de) * | 1997-12-17 | 1999-06-24 | Merck Patent Gmbh | Amid- und Harnstoffderivate |
US6333146B1 (en) | 1999-03-10 | 2001-12-25 | Fuji Photo Film Co., Ltd. | Methine compound and silver halide photographic material containing the same |
CN1351588A (zh) | 1999-04-02 | 2002-05-29 | 伊科斯公司 | 白细胞功能相关抗原与细胞间粘着分子结合的抑制剂及其用途 |
ES2264259T3 (es) | 1999-04-30 | 2006-12-16 | Trustees Of The University Of Pennsylvania | Agentes de obtencion de imagenes por spect (tomografia por emision de foton unico) para transportador de serotonina. |
BR0012984A (pt) | 1999-08-04 | 2002-07-16 | Millennium Pharm Inc | Método para tratar um estado associado com o mc4-r em um mamìfero, composto de ligação ao mc4-r, e, composição farmacêutica |
OA12062A (en) | 1999-10-13 | 2006-05-03 | Pfizer Prod Inc | Biaryl ether derivatives useful as monoamine reuptake inhibitors. |
US6410736B1 (en) | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
HUP0203722A3 (en) | 1999-12-30 | 2005-03-29 | Lundbeck & Co As H | Substituted phenyl-piperazine derivatives, pharmaceutical compositions containing them and their use |
PT1464641E (pt) * | 1999-12-30 | 2008-07-01 | Lundbeck & Co As H | Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetrahidropiridilo como antagonistas da dopamina d4 |
IL150337A0 (en) * | 1999-12-30 | 2002-12-01 | Lundbeck & Co As H | Phenylpiperazinyl derivatives |
DE60129420T2 (de) | 2000-02-29 | 2008-04-03 | MediQuest Therapeutics, Inc., Bothell | Melanocyt-tyrosinase hemmer als topische hautdepigmentierende mittel |
KR20020097484A (ko) | 2000-05-19 | 2002-12-31 | 다케다 야쿠힌 고교 가부시키가이샤 | β-씨크리타아제 억제제 |
US6455738B1 (en) | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
EP1302462A4 (en) | 2000-07-17 | 2007-07-18 | Takeda Pharmaceutical | Sulphonic derivatives, process for their preparation and their use |
WO2002015910A1 (en) | 2000-08-18 | 2002-02-28 | Sterix Limited | 2-substituted estradiol derivative for inhibiting superoxid dismutase |
US6753429B2 (en) | 2000-09-01 | 2004-06-22 | Fmc Corporation | 1,4-disubstituted benzenes as insecticides |
AU2001288623A1 (en) | 2000-09-05 | 2002-03-22 | Tularik, Inc. | Fxr modulators |
EP1193268A1 (en) | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
ES2287159T3 (es) | 2000-10-06 | 2007-12-16 | Biocompatibles Uk Limited | Polimeros ionicos bipolares. |
US20020173524A1 (en) | 2000-10-11 | 2002-11-21 | Tularik Inc. | Modulation of CCR4 function |
SK287337B6 (sk) | 2000-11-14 | 2010-07-07 | Merck Patent Gmbh | Použitie zlúčenín, ktoré sú kombinovanými selektívnymi inhibítormi (SSRI) reabsorpcie serotonínu (5-HT) a agonistami receptora 5-HT1A na výrobu liečiva |
US6436938B1 (en) | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
WO2002062766A2 (en) | 2001-02-07 | 2002-08-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
IL158997A0 (en) | 2001-06-07 | 2004-05-12 | Hoffmann La Roche | New indole derivatives with 5-ht6 receptor affinity |
EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
US7064139B2 (en) | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
BR0214164A (pt) | 2001-11-14 | 2004-09-28 | Schering Corp | Ligantes do receptor canabinóide |
CA2467337A1 (en) | 2001-12-21 | 2003-07-10 | H. Lundbeck A/S | Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
WO2003062290A1 (en) | 2002-01-16 | 2003-07-31 | Biocompatibles Uk Limited | Polymer conjugates |
US20050261298A1 (en) | 2002-01-18 | 2005-11-24 | David Solow-Cordero | Methods of treating conditions associated with an Edg-7 receptor |
EP1524552B1 (en) | 2002-03-01 | 2009-08-19 | FUJIFILM Corporation | Silver halide color photographic light-sensitive material |
AU2003211439B2 (en) | 2002-03-04 | 2008-11-20 | Japan Science And Technology Agency | Novel phosphonamides, process for producing the same, and use thereof |
KR101058483B1 (ko) | 2002-03-29 | 2011-08-24 | 유니버셜 디스플레이 코포레이션 | 반도체 나노결정을 포함하는 발광 소자 |
DE10217006A1 (de) | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
JP2005533809A (ja) | 2002-06-19 | 2005-11-10 | シェーリング コーポレイション | カンナビノイドレセプタアゴニスト |
TW200401641A (en) | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
CN1301970C (zh) | 2002-09-17 | 2007-02-28 | 弗·哈夫曼-拉罗切有限公司 | 2,4-取代吲哚和它们作为5-ht6调节剂的用途 |
DK1587788T3 (da) | 2002-09-17 | 2007-09-24 | Hoffmann La Roche | 2,7-substituerede indoler og anvendelsen deraf som 5-HT6-modulatorer |
EP1402888A1 (en) | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
US20040266732A1 (en) | 2002-09-20 | 2004-12-30 | Jorge Galvez | Therapeutic agents, methods, and treatments |
US20060189519A1 (en) * | 2002-09-26 | 2006-08-24 | Karl Volz | Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf) |
US20040137389A1 (en) | 2002-12-19 | 2004-07-15 | Kouta Fukui | Heat-developable light-sensitive material |
AU2003297398B2 (en) | 2002-12-20 | 2009-09-24 | Amgen Inc. | Asthma and allergic inflammation modulators |
US7189501B2 (en) | 2002-12-27 | 2007-03-13 | Fuji Photo Film Co., Ltd. | Silver halide color photographic photosensitive material |
DE10300098A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Ag | Kupfer-Carben-Komplexe und ihre Verwendung |
US7820753B2 (en) | 2003-02-05 | 2010-10-26 | Biocompatibles Uk Limited | Block copolymers |
AR043633A1 (es) | 2003-03-20 | 2005-08-03 | Schering Corp | Ligandos de receptores de canabinoides |
CA2520124A1 (en) | 2003-03-28 | 2004-10-14 | Chiron Corporation | Use of benzazole compounds for immunopotentiation |
US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
US20070060595A1 (en) | 2003-10-10 | 2007-03-15 | Toshio Yoshizawa | Novel fused heterocyclic compound and use thereof |
US7229751B2 (en) | 2003-11-20 | 2007-06-12 | Konica Minolta Medical & Graphic, Inc. | Silver salt photothermographic dry imaging material and image forming method using the same |
EP1694323A4 (en) | 2003-12-19 | 2009-05-13 | Elixir Pharmaceuticals Inc | METHOD FOR TREATING A DISEASE |
PL1701940T3 (pl) * | 2003-12-23 | 2008-11-28 | H Lundbeck As | Pochodne 2-(1H-indolilosulfanylo)benzyloaminy jako SSRI |
SE528250C2 (sv) | 2004-02-27 | 2006-10-03 | Calignum Technologies Ab | Komposition innefattande en initiator och ett förfarande för att behandla trä med kompositionen |
JP4569142B2 (ja) | 2004-03-22 | 2010-10-27 | コニカミノルタホールディングス株式会社 | 表示素子 |
JP4448730B2 (ja) | 2004-04-20 | 2010-04-14 | 富士フイルム株式会社 | 感光性組成物、該感光性組成物に用いられる化合物及び該感光性組成物を用いたパターン形成方法 |
US20090156471A1 (en) | 2004-07-15 | 2009-06-18 | Ramot At Tel Aviv University Ltd. | Use of anti-amyloid agents for treating and typing pathogen infections |
EP1793816B1 (en) | 2004-08-19 | 2012-01-04 | Tel Aviv University Future Technology Development L.P. | Compositions for treating amyloid associated diseases |
EP1793272A4 (en) | 2004-08-24 | 2008-01-23 | Fujifilm Corp | PHOTOGRAPHIC PHOTOSENSITIVE COLOR MATERIAL BASED ON SILVER HALIDE AND METHOD OF FORMING IMAGES |
EP1806337A4 (en) | 2004-10-08 | 2009-11-25 | Banyu Pharma Co Ltd | METHOD FOR THE SYNTHESIS OF A THIOETHER COMPOUND |
WO2006063606A1 (en) | 2004-12-16 | 2006-06-22 | Pirelli & C. S.P.A. | Process for manufacturing a thermoplastic elastomeric material |
-
2004
- 2004-12-21 PL PL04803045T patent/PL1701940T3/pl unknown
- 2004-12-21 SI SI200430784T patent/SI1701940T1/sl unknown
- 2004-12-21 JP JP2006545921A patent/JP4090491B2/ja not_active Expired - Fee Related
- 2004-12-21 WO PCT/DK2004/000894 patent/WO2005061455A1/en active Application Filing
- 2004-12-21 EP EP04803045A patent/EP1701940B1/en active Active
- 2004-12-21 DE DE602004014190T patent/DE602004014190D1/de active Active
- 2004-12-21 MX MXPA06007172A patent/MXPA06007172A/es active IP Right Grant
- 2004-12-21 RS RSP-2008/0315A patent/RS50589B/sr unknown
- 2004-12-21 BR BRPI0417858-0A patent/BRPI0417858B1/pt not_active IP Right Cessation
- 2004-12-21 AU AU2004303461A patent/AU2004303461B2/en not_active Ceased
- 2004-12-21 AT AT04803045T patent/ATE396970T1/de active
- 2004-12-21 DK DK04803045T patent/DK1701940T3/da active
- 2004-12-21 PT PT04803045T patent/PT1701940E/pt unknown
- 2004-12-21 ES ES04803045T patent/ES2303960T3/es active Active
-
2005
- 2005-12-21 US US11/314,702 patent/US7563908B2/en not_active Expired - Fee Related
-
2006
- 2006-06-04 IL IL176111A patent/IL176111A/en active IP Right Grant
-
2007
- 2007-06-05 JP JP2007148813A patent/JP4091648B2/ja active Active
- 2007-12-07 JP JP2007316676A patent/JP2008110984A/ja not_active Ceased
-
2008
- 2008-03-07 US US12/044,170 patent/US7652150B2/en not_active Expired - Fee Related
- 2008-03-17 US US12/049,401 patent/US7737170B2/en not_active Expired - Fee Related
- 2008-03-17 US US12/049,403 patent/US7737171B2/en not_active Expired - Fee Related
- 2008-06-19 HR HR20080274T patent/HRP20080274T3/hr unknown
- 2008-07-30 CY CY20081100801T patent/CY1108230T1/el unknown
-
2011
- 2011-05-20 CY CY20111100495T patent/CY1111733T1/el unknown
- 2011-05-27 HR HR20110400T patent/HRP20110400T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176111A0 (en) | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri | |
UA83875C2 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
UA102251C2 (ru) | Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера | |
SE0303180D0 (sv) | Novel compounds | |
TW200726753A (en) | 2,4-diamino-pyrimidines as aurora inhibitors | |
TW200531689A (en) | Therapeutic agents | |
MY142988A (en) | Novel aminobenzophenone compounds | |
MX2007011023A (es) | 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3. | |
IS8485A (is) | Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki | |
MY135841A (en) | Novel benzodioxoles | |
TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
TW200630374A (en) | Thiazolyldihydroindazoles | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
TW200745122A (en) | New compounds I | |
DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
MX2010002938A (es) | Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer. | |
MXPA05010000A (es) | Derivados de p-diaminobenceno substituidos. | |
EA200602180A1 (ru) | Производные 2-(1h-индолилсульфанил)ариламина для применения при лечении аффективных расстройств, боли, нгдв и стрессового недержания мочи | |
SE0401465D0 (sv) | New substituted piperdines as modulators of dopamine neurotransmission | |
GB0514811D0 (en) | Compounds | |
TW200745133A (en) | New compounds II | |
UA86873C2 (en) | SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES | |
MXPA05009282A (es) | Derivados de anilina sustituidos. | |
UA94054C2 (en) | Nitrocatechol derivatives as comt inhibitors |